Document is current
Any future updates will be listed below
-
Authors
Yorio, Jeffrey Thomas
Asnis-Alibozek, Aviva G.
Kasturi, Vijay
Hutson, Thomas E.
-
Funding
Funding for this research was provided by:
AVEO Oncology
- License Information
-
More Information
Article History
Received: 23 April 2024
Accepted: 12 September 2024
First Online: 25 October 2024
Declarations
:
: Not applicable.
: Not applicable.
: J.T.Y. has worked as a consultant or advisor for Incyte and Bristol-Myers Squibb, and on a Speaker’s Bureau for OncLive. A.G.A. has worked as a consultant for Aveo Oncology. V.K. was an employee of Aveo Oncology at the time the work was completed. T.E.H. has received speaker honoraria from Pfizer, Novartis, Eisai, Exelexis, Jansen, Bristol-Myers Squibb, Astra Zeneca, and Aveo Oncology.
